Stay updated with breaking news from Ellipses Pharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 200 oncologists worldwide now involved in assessment and selection of potential treatments Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development
EP0042 is currently being investigated as a potential treatment option for patients with acute myeloid leukaemia Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating
IND approval allows for US trial sites and recruitment of eligible US patients to be added to EP0042's ongoing phase 1/2 trial Ellipses Pharma ("Ellipses"), a global drug development company focused
A phase 1/2 trial to initiate across a range of patient populations with RET-altered cancers Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development
Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours SunRock Biopharma S.L. ("SunRock"), a biopharmaceutical company that is developing a portfolio